Current Staff
- Director: Benjamin Anderson, MD
- Supervisor: Sara Putala, BA
- Clinical Research Associate: Megan Calderado, LMFT
- Clinical Research Assistant: Lindsay Bernier, BS
- Clinical Research Assistant: Emma Redfield, BS
- Investigator: Tonya Ruggieri, MD
Overview
Psychiatric clinical trials are highly regulated research studies using human volunteers to test the safety and efficacy of novel psychiatric drugs and treatments. Clinical trials are essential for developing new methods to prevent, diagnose, and treat psychiatric disorders. By participating in a clinical trial, patients can take an active role in managing their symptoms, gain access to novel research treatments before they are widely available, and help others by advancing our scientific understanding of the causes and contributors of psychiatric conditions.
CLINICAL TRIALS UNIT
The Clinical Trials Unit is located on the Hartford Hospital / Institute of Living campus in Hartford, CT. The service, directed by Dr. Benjamin Anderson, conducts controlled, clinical testing in human subjects of investigational psychiatric drugs, therapeutic modalities, or combined treatments that are currently in development but not yet approved for use in routine clinical care. Investigational drugs and/or treatments can only be administered to eligible individuals who are enrolled in a formal research study.
All research and clinical studies at the Clinical Trials Unit are conducted under investigator-initiated or industry-sponsored protocols with financial support from pharmaceutical companies, government agencies, and/or non-profit entities. The Hartford Healthcare Institutional Review Board, in conjunction with study sponsors and regulatory authorities, reviews, approves, and oversees all research and clinical trials at the Clinical Trials Unit.
Below you can find more information about currently running research and clinical trials and participant eligibility criteria. If you or a loved one are interested in participating in a research or clinical trial, please contact us by calling 860.545.7476.
Participate in a Clinical Trial
Our current and upcoming studies are listed below. For more information or to see if you or your loved one are eligible to participate in an ongoing or upcoming study, please email us at clinical.trials@hhchealth.org or call us 860-545-7476. We look forward to hearing from you.
Clinical Trials - Recruiting Participants
ADOLESCENT SUICIDALITY
2024-Oui-001 (Oui) CURRENTLY RECRUITING PARTICIPANTS
Has your teen recently been hospitalized for suicidality? If so, your teen may qualify for this study.
This is a clinical study to assess the effect of a controlled pilot trial of mobile technology for reducing and preventing adolescent suicidality
Qualified participants include:
- Must be 13-17 years old
- Mix of in-person and remote visits
- Involves a study app
- History of suicidality
- Parent/ Guardian approval is required
Those that qualify will:
- Receive study-related care at no cost
- Reimbursement for travel or other expenses may be provided
For more information, contact clinical.trials@hhchealth.org or call us at 860.545.7476
|
BIPOLAR DEPRESSION
ABX-002-2002 (Autobahn) CURRENTLY RECRUITING PARTICIPANTS
Have you been diagnosed with bipolar disorder and are currently experiencing a depressive episode? This study may be for you!
This is a clinical study to assess the effect of adjunctively administered ABX-002 in adults with bipolar disorder experiencing an episode of depression.
Qualified Participants Include:
- Ages 18-65, who are currently experiencing a depressive episode
- Current diagnosis of bipolar disorder
- Able to undergo MRIs
- Taking at least one mood stabilizer and/or second-generation antipsychotic
Those that qualify will:
- Receive study-related care at no cost
- Reimbursement for travel or other expenses may be provided
For more information, contact clinical.trials@hhchealth.org or call us at 860.545.7476
|
SCHIZOPHRENIA
CN012-0077 (Northwell) CURRENTLY RECRUITING PARTICIPANTS
Have you been diagnosed with Schizophrenia and received your first antipsychotic treatment within the last 5 years? If so this study may be for you!
This clinical trial is an open-label study to evaluate the efficacy and tolerability of cobenfy in first episode/early phase schizophrenia patients
Qualified participants include:
- Must be 18 and older
- Meet diagnostic criteria for schizophrenia
- Must have started first dose of antipsychotic treatment within the past 5 years
Those that qualify will:
- Receive study-related care at no cost
- Reimbursement for travel or other expenses may be provided
For more information, contact clinical.trials@hhchealth.org or call us at 860.545.7476
|
MAJOR DEPRESSIVE DISORDER
XPF-010-D302 (Xenon) CURRENTLY RECRUITING PARTICIPANTS
Have you been diagnosed with major depressive disorder and are currently experiencing a depressive episode? This study may be for you!
This clinical trial is a phase 3, randomized, double-blind, placebo-controlled, multicenter study to evaluate a new mechanism of anti-depressant treatment in those experiencing moderate-to-severe major depressive disorder
Qualified Participants Include:
- Must be 18 – 74 years of age.
- Have a primary diagnosis of major depressive disorder
- Must meet study criteria and be able to follow study protocol for about 18 weeks
Those that qualify will:
- Receive study-related care at no cost
- Reimbursement for travel or other expenses may be provided
For more information, contact clinical.trials@hhchealth.org or call us at 860.545.7476
|
Clinical Trials - Currently Active
NO CLINICAL TRIALS ARE CURRENTLY ACTIVE
|
Back to Top
Upcoming Clinical Trials
NO CLINICAL TRIALS ARE UPCOMING
|
Back to Top